Profile of neratinib and its potential in the treatment of breast cancer
- Publisher: Dove Press
Breast Cancer: Targets and Therapy,
(issn: 1179-1314, eissn: 1179-1314)
pan-HER inhibitor | neratinib | Review | HKI 272 | HER (ErbB) | irreversible tyrosine kinase inhibitor | RC254-282 | breast cancer | Targets and Therapy [Breast Cancer] | Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Katharina Feldinger,1 Anthony Kong,2 1Department of Oncology, The Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, 2The Robert Aitkin Institute, School of Cancer Sciences, University of Birmingham, Birmingham, UK Abstract: The HER (ErbB) recept...